For: | Zhu XD, Lin GJ, Qian LP, Chen ZQ. Expression of survivin in human gastric carcinoma and gastric carcinoma model of rats. World J Gastroenterol 2003; 9(7): 1435-1438 [PMID: 12854136 DOI: 10.3748/wjg.v9.i7.1435] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i7/1435.htm |
Number | Citing Articles |
1 |
Qi-lian Liang, Bi-rong Wang, Guo-hong Li. DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters. Journal of Zhejiang University SCIENCE B 2009; 10(9): 675 doi: 10.1631/jzus.B0920077
|
2 |
De-Jian Dai, Cai-De Lu, Ri-Yong Lai, Jun-Ming Guo, Hua Meng, Wei-Sheng Chen, Jun Gu. Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells. World Journal of Gastroenterology 2005; 11(2): 193-199 doi: 10.3748/wjg.v11.i2.193
|
3 |
Yunbo Wei, Tingjun Fan, Miaomiao Yu. Inhibitor of apoptosis proteins and apoptosis. Acta Biochimica et Biophysica Sinica 2008; 40(4): 278 doi: 10.1111/j.1745-7270.2008.00407.x
|
4 |
Andreas Krieg, Billur Baseras, Monika Tomczak, Pablo Emilio Verde, Nikolas Hendrik Stoecklein, Wolfram Trudo Knoefel. Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis. Molecular Biology Reports 2013; 40(9): 5501 doi: 10.1007/s11033-013-2650-z
|
5 |
Metin Budak, Mustafa Yildiz. Lung Cancer - Strategies for Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.78367
|
6 |
Qing Chang, Zheng-Ren Liu, Da-Yu Wang, Manoj Kumar, Yi-Bei Chen, Ren-Yi Qin. Survivin expression induced by doxorubicin in cholangiocarcinoma. World Journal of Gastroenterology 2004; 10(3): 415-418 doi: 10.3748/wjg.v10.i3.415
|
7 |
Amirreza Mahmoudzadeh-Sagheb, Mehran Panahi, Setareh Jami, Bita Moudi, Hamidreza Mahmoudzadeh-Sagheb, Zahra Heidari. Survivin as a potential biomarker for early diagnosis of the progression of precancerous lesions to gastric cancer. The International Journal of Biological Markers 2024; 39(1): 52 doi: 10.1177/03936155231217268
|
8 |
Eiman Adel Hasby, Mohammed Alaa Mokhtar. Survivin immunohistochemical expression in hepatocellular carcinoma: Correlation with tumour differentiation and proliferation. Arab Journal of Gastroenterology 2010; 11(3): 141 doi: 10.1016/j.ajg.2010.07.001
|
9 |
Chao Zhang, Zhan-Kui Liu, Pei-Wu Yu. Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation. World Journal of Gastroenterology 2004; 10(10): 1537-1539 doi: 10.3748/wjg.v10.i10.1537
|
10 |
Zhen-Ning Wang, Hui-Mian Xu, Li Jiang, Xin Zhou, Chong Lu, Xue Zhang. Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World Journal of Gastroenterology 2004; 10(21): 3094-3098 doi: 10.3748/wjg.v10.i21.3094
|
11 |
Wenmei Chen, Wenjing Dong, Jintai Wang, Zirong Wen, Xinjie Hao. Elevated Expressions of Survivin and Endoglin in Patients with Hepatic Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2019; 34(1): 7 doi: 10.1089/cbr.2018.2539
|
12 |
Alex J. Félix, Carlos J. Ciudad, Véronique Noé. Functional pharmacogenomics and toxicity of PolyPurine Reverse Hoogsteen hairpins directed against survivin in human cells. Biochemical Pharmacology 2018; 155: 8 doi: 10.1016/j.bcp.2018.06.020
|
13 |
Wei-Chang Chen, Qiang Liu, Jian-Xin Fu, Su-Ya Kang. Expression of survivin and its significance in colorectal cancer. World Journal of Gastroenterology 2004; 10(19): 2886-2889 doi: 10.3748/wjg.v10.i19.2886
|
14 |
Sheng-Quan Cheng, Wen-Liang Wang, Wei Yan, Qing-Long Li, Li Wang, Wen-Yong Wang. Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721. World Journal of Gastroenterology 2005; 11(5): 756-759 doi: 10.3748/wjg.v11.i5.756
|
15 |
Li Yang, Huaijun Zhu, Bo Zhou, Haijuan Gu, Hongli Yan, Naping Tang, Hanzhang Dong, Qingmin Sun, Rihong Cong, Guoyu Chen, Bin Wang. The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese Population. Digestive Diseases and Sciences 2009; 54(5): 1021 doi: 10.1007/s10620-008-0441-5
|